Business Description
Polaris Group
ISIN : KYG7171A1085
Description
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.88 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | -0.71 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -2.6 | |||||
Beneish M-Score | -3.18 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 80.6 | |||||
3-Year EBITDA Growth Rate | -49.4 | |||||
3-Year EPS without NRI Growth Rate | -48.1 | |||||
3-Year FCF Growth Rate | -40.3 | |||||
3-Year Book Growth Rate | -19.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.93 | |||||
9-Day RSI | 55.12 | |||||
14-Day RSI | 50.93 | |||||
3-1 Month Momentum % | -26.15 | |||||
6-1 Month Momentum % | -66.39 | |||||
12-1 Month Momentum % | -72.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.8 | |||||
Quick Ratio | 4.58 | |||||
Cash Ratio | 4.2 | |||||
Days Inventory | 113.67 | |||||
Days Sales Outstanding | 58.51 | |||||
Days Payable | 4.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | -34.12 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -399.04 | |||||
Operating Margin % | -3967.89 | |||||
Net Margin % | -5508.02 | |||||
EBITDA Margin % | -4827.19 | |||||
FCF Margin % | -4414.85 | |||||
OCF Margin % | -3327.3 | |||||
ROE % | -75.93 | |||||
ROA % | -46.33 | |||||
ROIC % | -45.71 | |||||
3-Year ROIIC % | -49.53 | |||||
ROC (Joel Greenblatt) % | -107.75 | |||||
ROCE % | -50.92 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 136.47 | |||||
PB Ratio | 2.08 | |||||
Price-to-Tangible-Book | 2.47 | |||||
EV-to-EBIT | -2.86 | |||||
EV-to-EBITDA | -3.19 | |||||
EV-to-Revenue | 153.89 | |||||
EV-to-FCF | -3.49 | |||||
Price-to-GF-Value | 0.22 | |||||
Earnings Yield (Greenblatt) % | -34.97 | |||||
FCF Yield % | -29.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Polaris Group Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 69.265 | ||
| EPS (TTM) (NT$) | -4.88 | ||
| Beta | -1.0718 | ||
| 3-Year Sharpe Ratio | -1.79 | ||
| 3-Year Sortino Ratio | -1.67 | ||
| Volatility % | 49.93 | ||
| 14-Day RSI | 50.93 | ||
| 14-Day ATR (NT$) | 0.578698 | ||
| 20-Day SMA (NT$) | 11.1125 | ||
| 12-1 Month Momentum % | -72.22 | ||
| 52-Week Range (NT$) | 10.1 - 44.55 | ||
| Shares Outstanding (Mil) | 894.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Polaris Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Polaris Group Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 0.519502:1 Stock Split | 2026-09-17 | In 23 days |
Show
Entries
Polaris Group Frequently Asked Questions
What is Polaris Group(TPE:6550)'s stock price today?
The current price of TPE:6550 is NT$11.60. The 52 week high of TPE:6550 is NT$44.55 and 52 week low is NT$10.10.
When is next earnings date of Polaris Group(TPE:6550)?
The next earnings date of Polaris Group(TPE:6550) is .
Does Polaris Group(TPE:6550) pay dividends? If so, how much?
Polaris Group(TPE:6550) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Polaris Group
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers